Free Trial

Verve Therapeutics (VERV) Insider Trading & Ownership

Verve Therapeutics logo
$5.73
-0.06 (-1.04%)
(As of 10/31/2024 ET)

Verve Therapeutics (NASDAQ:VERV) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
19.30%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$475,760.00
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$18,818.66
Get VERV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Verve Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VERV Insider Buying and Selling by Quarter

Verve Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/14/2024Andrew D AsheInsiderBuy76,000$6.26$475,760.00  
4/2/2024Joan NickersonInsiderSell1,514$8.24$12,475.36  
11/29/2023Allison DorvalCFOSell554$11.45$6,343.30  
(Data available from 1/1/2013 forward)

VERV Insider Trading Activity - Frequently Asked Questions

The list of insiders at Verve Therapeutics includes 2017 Gp L.L.C. Gv, Allison Dorval, Andrew Bellinger, Andrew D Ashe, Burt A Adelman, Fmr Llc, Joan Nickerson, Krishna Yeshwant, and Sekar Kathiresan. Learn more on insiders at VERV.

19.30% of Verve Therapeutics stock is owned by insiders. Learn more on VERV's insider holdings.

The following insider purchased VERV shares in the last 24 months: Andrew D Ashe ($475,760.00).

Insiders have purchased a total of 76,000 VERV shares in the last 24 months for a total of $475,760.00 bought.

The following insiders have sold VERV shares in the last 24 months: 2017 Gp L.L.C. Gv ($9,234,884.58), Allison Dorval ($18,586.70), Andrew Bellinger ($19,851.75), Joan Nickerson ($12,475.36), and Krishna Yeshwant ($3,700,148.16).

Insiders have sold a total of 368,613 Verve Therapeutics shares in the last 24 months for a total of $12,985,946.55 sold.



This page (NASDAQ:VERV) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners